Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Will HHS Ruling on COVID-19 LDTs Be Good or Bad for Lab Reimbursement?

COVID-19 LDTs Decision Could Be Negative for Reimbursement

This is an excerpt of a 1,028-word article in the September 14, 2020 issue of THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. WHILE SOME LABS CELEBRATE THE PERCEIVED FLEXIBILITY that comes from not having to get an emergency use authorization (EUA) for COVID-19 laboratory-developed tests (LDTs), there is a potential …

Will HHS Ruling on COVID-19 LDTs Be Good or Bad for Lab Reimbursement? Read More »

To access this post, you must purchase The Dark Report.

Comments

;